Eribulin mesylate versus ixabepilone in patients with metastatic breast cancer: a randomized Phase II study comparing the incidence of peripheral neuropathy

Peripheral neuropathy is a common toxicity associated with tubulin-targeted chemotherapeutic agents. This Phase II study compares the incidence and severity of neuropathy associated with eribulin mesylate or ixabepilone in metastatic breast cancer (MBC). The primary objective was to assess the incid...

Descripción completa

Detalles Bibliográficos
Autores principales: Vahdat, Linda T., Garcia, Agustin A., Vogel, Charles, Pellegrino, Christine, Lindquist, Deborah L., Iannotti, Nicholas, Gopalakrishna, Prashanth, Sparano, Joseph A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2013
Materias:
Clinical Trial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3732762/
https://www.ncbi.nlm.nih.gov/pubmed/23877339
http://dx.doi.org/10.1007/s10549-013-2574-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3732762/
https://www.ncbi.nlm.nih.gov/pubmed/23877339
http://dx.doi.org/10.1007/s10549-013-2574-2

Ejemplares similares